Subclinical Vitamin K Deficiency in Hemodialysis Patients

Background Subclinical vitamin K deficiency increasingly is associated with extraosseous calcification in healthy adults. Nondietary determinants of vitamin K status include apolipoprotein E (apoE) genotype, which may influence vitamin K transport to peripheral tissues. Methods Serum phylloquinone c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of kidney diseases 2007-03, Vol.49 (3), p.432-439
Hauptverfasser: Pilkey, Rachel M., MD, Morton, A. Ross, MD, Boffa, Michael B., PhD, Noordhof, Curtis, Day, Andrew G., MSc, Su, Yinghua, BSc, Miller, Lisa M., MD, Koschinsky, Marlys L., PhD, Booth, Sarah L., PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 439
container_issue 3
container_start_page 432
container_title American journal of kidney diseases
container_volume 49
creator Pilkey, Rachel M., MD
Morton, A. Ross, MD
Boffa, Michael B., PhD
Noordhof, Curtis
Day, Andrew G., MSc
Su, Yinghua, BSc
Miller, Lisa M., MD
Koschinsky, Marlys L., PhD
Booth, Sarah L., PhD
description Background Subclinical vitamin K deficiency increasingly is associated with extraosseous calcification in healthy adults. Nondietary determinants of vitamin K status include apolipoprotein E (apoE) genotype, which may influence vitamin K transport to peripheral tissues. Methods Serum phylloquinone concentrations and percentage of uncarboxyated osteocalcin (%ucOC) were measured by means of high-performance liquid chromatography and radioimmunoassay in 142 hemodialysis patients, respectively. ApoE phenotype was determined by means of isoelectric focusing of delipidated serum samples and Western blot analysis. Clinical and laboratory data were obtained by using chart review. Results Mean age was 62.6 ± 14.8 (SD) years. Mean phylloquinone level was 0.99 ± 1.12 nmol/L; 29% of patients had levels less than 0.4 nmol/L. There was no association between phylloquinone level and %ucOC. There were positive correlations between phylloquinone and total cholesterol ( P = 0.017), triglyceride ( P = 0.022), and ionized calcium levels ( P = 0.019). There was a negative correlation between phylloquinone level and dialysis adequacy ( P = 0.002). Mean %ucOC was 51.1% ± 25.8%, and 93% of subjects had values greater than 20%. There were positive correlations between %ucOC and dialysis vintage ( P < 0.001), phosphate level ( P < 0.001), parathyroid hormone level ( P < 0.001), albumin level ( P = 0.035), and ionized calcium level ( P = 0.046). Seventeen percent of patients were apoE4. Mean %ucOC was significantly greater in apoE4 carriers compared with all other apoE phenotypes (60.1% ± 28.4% versus 47.8% ± 24.4%; P = 0.035). In multiple regression analysis with phylloquinone level forced in, independent predictors of %ucOC were phosphate level, dialysis vintage, parathyroid hormone level, and apoE4. Conclusion These data indicate suboptimal vitamin K status in hemodialysis patients, shown by low phylloquinone concentrations and high %ucOC in 29% and 93% of subjects, respectively. The apoE4 allele influences osteocalcin γ-carboxylation in hemodialysis patients.
doi_str_mv 10.1053/j.ajkd.2006.11.041
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70219559</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S027263860601835X</els_id><sourcerecordid>70219559</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-d275c1e2085bf51455a3eb7df9704eee39934175f0411c3f171199ef607fc7cb3</originalsourceid><addsrcrecordid>eNp9kV2L1TAQhoO4uMfVP-CF9Ebv2p1pmqYBEWT92MUFhVXxLqTpBNLtx5q0wvn3pp4jC3vhVRjyvDPDM4y9QCgQBD_vC9PfdkUJUBeIBVT4iO1QlDyvG948ZjsoZZnXvKlP2dMYewBQvK6fsFOUnNcSxI6pm7W1g5-8NUP2wy9m9FP2OXtPzltPk91nqb6kce68GfbRx-yrWdLHEp-xE2eGSM-P7xn7_vHDt4vL_PrLp6uLd9e5rbha8q6UwiKV0IjWCayEMJxa2TkloSIirhSvUAqX1kfLHUpEpcjVIJ2VtuVn7PWh712Yf60UFz36aGkYzETzGrWEEpUQKoHlAbRhjjGQ03fBjybsNYLehOleb8L0Jkwj6jQxhV4eu6_tSN195GgoAa-OgInJkQtmsj7ecwoBhNqmvzlwlFz89hR0_CuQOh_ILrqb_f_3ePsg_u8qt7Sn2M9rmJJljTqWGvTNdtrtslADNlz85H8A7RuciA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70219559</pqid></control><display><type>article</type><title>Subclinical Vitamin K Deficiency in Hemodialysis Patients</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Pilkey, Rachel M., MD ; Morton, A. Ross, MD ; Boffa, Michael B., PhD ; Noordhof, Curtis ; Day, Andrew G., MSc ; Su, Yinghua, BSc ; Miller, Lisa M., MD ; Koschinsky, Marlys L., PhD ; Booth, Sarah L., PhD</creator><creatorcontrib>Pilkey, Rachel M., MD ; Morton, A. Ross, MD ; Boffa, Michael B., PhD ; Noordhof, Curtis ; Day, Andrew G., MSc ; Su, Yinghua, BSc ; Miller, Lisa M., MD ; Koschinsky, Marlys L., PhD ; Booth, Sarah L., PhD</creatorcontrib><description>Background Subclinical vitamin K deficiency increasingly is associated with extraosseous calcification in healthy adults. Nondietary determinants of vitamin K status include apolipoprotein E (apoE) genotype, which may influence vitamin K transport to peripheral tissues. Methods Serum phylloquinone concentrations and percentage of uncarboxyated osteocalcin (%ucOC) were measured by means of high-performance liquid chromatography and radioimmunoassay in 142 hemodialysis patients, respectively. ApoE phenotype was determined by means of isoelectric focusing of delipidated serum samples and Western blot analysis. Clinical and laboratory data were obtained by using chart review. Results Mean age was 62.6 ± 14.8 (SD) years. Mean phylloquinone level was 0.99 ± 1.12 nmol/L; 29% of patients had levels less than 0.4 nmol/L. There was no association between phylloquinone level and %ucOC. There were positive correlations between phylloquinone and total cholesterol ( P = 0.017), triglyceride ( P = 0.022), and ionized calcium levels ( P = 0.019). There was a negative correlation between phylloquinone level and dialysis adequacy ( P = 0.002). Mean %ucOC was 51.1% ± 25.8%, and 93% of subjects had values greater than 20%. There were positive correlations between %ucOC and dialysis vintage ( P &lt; 0.001), phosphate level ( P &lt; 0.001), parathyroid hormone level ( P &lt; 0.001), albumin level ( P = 0.035), and ionized calcium level ( P = 0.046). Seventeen percent of patients were apoE4. Mean %ucOC was significantly greater in apoE4 carriers compared with all other apoE phenotypes (60.1% ± 28.4% versus 47.8% ± 24.4%; P = 0.035). In multiple regression analysis with phylloquinone level forced in, independent predictors of %ucOC were phosphate level, dialysis vintage, parathyroid hormone level, and apoE4. Conclusion These data indicate suboptimal vitamin K status in hemodialysis patients, shown by low phylloquinone concentrations and high %ucOC in 29% and 93% of subjects, respectively. The apoE4 allele influences osteocalcin γ-carboxylation in hemodialysis patients.</description><identifier>ISSN: 0272-6386</identifier><identifier>EISSN: 1523-6838</identifier><identifier>DOI: 10.1053/j.ajkd.2006.11.041</identifier><identifier>PMID: 17336705</identifier><language>eng</language><publisher>Orlando, FL: Elsevier Inc</publisher><subject>Aged ; Alleles ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; apolipoprotein E ; Apolipoproteins E - genetics ; Apolipoproteins E - physiology ; Biological and medical sciences ; Biological Transport - physiology ; Cohort Studies ; Cross-Sectional Studies ; Emergency and intensive care: renal failure. Dialysis management ; Female ; hemodialysis ; Humans ; Intensive care medicine ; Male ; Medical sciences ; Middle Aged ; Nephrology ; Nephrology. Urinary tract diseases ; osteocalcin ; Osteocalcin - metabolism ; Phenotype ; phylloquinone ; Regression Analysis ; Renal Dialysis - adverse effects ; Vitamin K ; Vitamin K 1 - blood ; Vitamin K Deficiency - epidemiology ; Vitamin K Deficiency - genetics ; Vitamin K Deficiency - metabolism ; γ-carboxylation</subject><ispartof>American journal of kidney diseases, 2007-03, Vol.49 (3), p.432-439</ispartof><rights>National Kidney Foundation, Inc.</rights><rights>2007 National Kidney Foundation, Inc.</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-d275c1e2085bf51455a3eb7df9704eee39934175f0411c3f171199ef607fc7cb3</citedby><cites>FETCH-LOGICAL-c439t-d275c1e2085bf51455a3eb7df9704eee39934175f0411c3f171199ef607fc7cb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1053/j.ajkd.2006.11.041$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19100599$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17336705$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pilkey, Rachel M., MD</creatorcontrib><creatorcontrib>Morton, A. Ross, MD</creatorcontrib><creatorcontrib>Boffa, Michael B., PhD</creatorcontrib><creatorcontrib>Noordhof, Curtis</creatorcontrib><creatorcontrib>Day, Andrew G., MSc</creatorcontrib><creatorcontrib>Su, Yinghua, BSc</creatorcontrib><creatorcontrib>Miller, Lisa M., MD</creatorcontrib><creatorcontrib>Koschinsky, Marlys L., PhD</creatorcontrib><creatorcontrib>Booth, Sarah L., PhD</creatorcontrib><title>Subclinical Vitamin K Deficiency in Hemodialysis Patients</title><title>American journal of kidney diseases</title><addtitle>Am J Kidney Dis</addtitle><description>Background Subclinical vitamin K deficiency increasingly is associated with extraosseous calcification in healthy adults. Nondietary determinants of vitamin K status include apolipoprotein E (apoE) genotype, which may influence vitamin K transport to peripheral tissues. Methods Serum phylloquinone concentrations and percentage of uncarboxyated osteocalcin (%ucOC) were measured by means of high-performance liquid chromatography and radioimmunoassay in 142 hemodialysis patients, respectively. ApoE phenotype was determined by means of isoelectric focusing of delipidated serum samples and Western blot analysis. Clinical and laboratory data were obtained by using chart review. Results Mean age was 62.6 ± 14.8 (SD) years. Mean phylloquinone level was 0.99 ± 1.12 nmol/L; 29% of patients had levels less than 0.4 nmol/L. There was no association between phylloquinone level and %ucOC. There were positive correlations between phylloquinone and total cholesterol ( P = 0.017), triglyceride ( P = 0.022), and ionized calcium levels ( P = 0.019). There was a negative correlation between phylloquinone level and dialysis adequacy ( P = 0.002). Mean %ucOC was 51.1% ± 25.8%, and 93% of subjects had values greater than 20%. There were positive correlations between %ucOC and dialysis vintage ( P &lt; 0.001), phosphate level ( P &lt; 0.001), parathyroid hormone level ( P &lt; 0.001), albumin level ( P = 0.035), and ionized calcium level ( P = 0.046). Seventeen percent of patients were apoE4. Mean %ucOC was significantly greater in apoE4 carriers compared with all other apoE phenotypes (60.1% ± 28.4% versus 47.8% ± 24.4%; P = 0.035). In multiple regression analysis with phylloquinone level forced in, independent predictors of %ucOC were phosphate level, dialysis vintage, parathyroid hormone level, and apoE4. Conclusion These data indicate suboptimal vitamin K status in hemodialysis patients, shown by low phylloquinone concentrations and high %ucOC in 29% and 93% of subjects, respectively. The apoE4 allele influences osteocalcin γ-carboxylation in hemodialysis patients.</description><subject>Aged</subject><subject>Alleles</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>apolipoprotein E</subject><subject>Apolipoproteins E - genetics</subject><subject>Apolipoproteins E - physiology</subject><subject>Biological and medical sciences</subject><subject>Biological Transport - physiology</subject><subject>Cohort Studies</subject><subject>Cross-Sectional Studies</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Female</subject><subject>hemodialysis</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nephrology</subject><subject>Nephrology. Urinary tract diseases</subject><subject>osteocalcin</subject><subject>Osteocalcin - metabolism</subject><subject>Phenotype</subject><subject>phylloquinone</subject><subject>Regression Analysis</subject><subject>Renal Dialysis - adverse effects</subject><subject>Vitamin K</subject><subject>Vitamin K 1 - blood</subject><subject>Vitamin K Deficiency - epidemiology</subject><subject>Vitamin K Deficiency - genetics</subject><subject>Vitamin K Deficiency - metabolism</subject><subject>γ-carboxylation</subject><issn>0272-6386</issn><issn>1523-6838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV2L1TAQhoO4uMfVP-CF9Ebv2p1pmqYBEWT92MUFhVXxLqTpBNLtx5q0wvn3pp4jC3vhVRjyvDPDM4y9QCgQBD_vC9PfdkUJUBeIBVT4iO1QlDyvG948ZjsoZZnXvKlP2dMYewBQvK6fsFOUnNcSxI6pm7W1g5-8NUP2wy9m9FP2OXtPzltPk91nqb6kce68GfbRx-yrWdLHEp-xE2eGSM-P7xn7_vHDt4vL_PrLp6uLd9e5rbha8q6UwiKV0IjWCayEMJxa2TkloSIirhSvUAqX1kfLHUpEpcjVIJ2VtuVn7PWh712Yf60UFz36aGkYzETzGrWEEpUQKoHlAbRhjjGQ03fBjybsNYLehOleb8L0Jkwj6jQxhV4eu6_tSN195GgoAa-OgInJkQtmsj7ecwoBhNqmvzlwlFz89hR0_CuQOh_ILrqb_f_3ePsg_u8qt7Sn2M9rmJJljTqWGvTNdtrtslADNlz85H8A7RuciA</recordid><startdate>20070301</startdate><enddate>20070301</enddate><creator>Pilkey, Rachel M., MD</creator><creator>Morton, A. Ross, MD</creator><creator>Boffa, Michael B., PhD</creator><creator>Noordhof, Curtis</creator><creator>Day, Andrew G., MSc</creator><creator>Su, Yinghua, BSc</creator><creator>Miller, Lisa M., MD</creator><creator>Koschinsky, Marlys L., PhD</creator><creator>Booth, Sarah L., PhD</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070301</creationdate><title>Subclinical Vitamin K Deficiency in Hemodialysis Patients</title><author>Pilkey, Rachel M., MD ; Morton, A. Ross, MD ; Boffa, Michael B., PhD ; Noordhof, Curtis ; Day, Andrew G., MSc ; Su, Yinghua, BSc ; Miller, Lisa M., MD ; Koschinsky, Marlys L., PhD ; Booth, Sarah L., PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-d275c1e2085bf51455a3eb7df9704eee39934175f0411c3f171199ef607fc7cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aged</topic><topic>Alleles</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>apolipoprotein E</topic><topic>Apolipoproteins E - genetics</topic><topic>Apolipoproteins E - physiology</topic><topic>Biological and medical sciences</topic><topic>Biological Transport - physiology</topic><topic>Cohort Studies</topic><topic>Cross-Sectional Studies</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Female</topic><topic>hemodialysis</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nephrology</topic><topic>Nephrology. Urinary tract diseases</topic><topic>osteocalcin</topic><topic>Osteocalcin - metabolism</topic><topic>Phenotype</topic><topic>phylloquinone</topic><topic>Regression Analysis</topic><topic>Renal Dialysis - adverse effects</topic><topic>Vitamin K</topic><topic>Vitamin K 1 - blood</topic><topic>Vitamin K Deficiency - epidemiology</topic><topic>Vitamin K Deficiency - genetics</topic><topic>Vitamin K Deficiency - metabolism</topic><topic>γ-carboxylation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pilkey, Rachel M., MD</creatorcontrib><creatorcontrib>Morton, A. Ross, MD</creatorcontrib><creatorcontrib>Boffa, Michael B., PhD</creatorcontrib><creatorcontrib>Noordhof, Curtis</creatorcontrib><creatorcontrib>Day, Andrew G., MSc</creatorcontrib><creatorcontrib>Su, Yinghua, BSc</creatorcontrib><creatorcontrib>Miller, Lisa M., MD</creatorcontrib><creatorcontrib>Koschinsky, Marlys L., PhD</creatorcontrib><creatorcontrib>Booth, Sarah L., PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of kidney diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pilkey, Rachel M., MD</au><au>Morton, A. Ross, MD</au><au>Boffa, Michael B., PhD</au><au>Noordhof, Curtis</au><au>Day, Andrew G., MSc</au><au>Su, Yinghua, BSc</au><au>Miller, Lisa M., MD</au><au>Koschinsky, Marlys L., PhD</au><au>Booth, Sarah L., PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Subclinical Vitamin K Deficiency in Hemodialysis Patients</atitle><jtitle>American journal of kidney diseases</jtitle><addtitle>Am J Kidney Dis</addtitle><date>2007-03-01</date><risdate>2007</risdate><volume>49</volume><issue>3</issue><spage>432</spage><epage>439</epage><pages>432-439</pages><issn>0272-6386</issn><eissn>1523-6838</eissn><abstract>Background Subclinical vitamin K deficiency increasingly is associated with extraosseous calcification in healthy adults. Nondietary determinants of vitamin K status include apolipoprotein E (apoE) genotype, which may influence vitamin K transport to peripheral tissues. Methods Serum phylloquinone concentrations and percentage of uncarboxyated osteocalcin (%ucOC) were measured by means of high-performance liquid chromatography and radioimmunoassay in 142 hemodialysis patients, respectively. ApoE phenotype was determined by means of isoelectric focusing of delipidated serum samples and Western blot analysis. Clinical and laboratory data were obtained by using chart review. Results Mean age was 62.6 ± 14.8 (SD) years. Mean phylloquinone level was 0.99 ± 1.12 nmol/L; 29% of patients had levels less than 0.4 nmol/L. There was no association between phylloquinone level and %ucOC. There were positive correlations between phylloquinone and total cholesterol ( P = 0.017), triglyceride ( P = 0.022), and ionized calcium levels ( P = 0.019). There was a negative correlation between phylloquinone level and dialysis adequacy ( P = 0.002). Mean %ucOC was 51.1% ± 25.8%, and 93% of subjects had values greater than 20%. There were positive correlations between %ucOC and dialysis vintage ( P &lt; 0.001), phosphate level ( P &lt; 0.001), parathyroid hormone level ( P &lt; 0.001), albumin level ( P = 0.035), and ionized calcium level ( P = 0.046). Seventeen percent of patients were apoE4. Mean %ucOC was significantly greater in apoE4 carriers compared with all other apoE phenotypes (60.1% ± 28.4% versus 47.8% ± 24.4%; P = 0.035). In multiple regression analysis with phylloquinone level forced in, independent predictors of %ucOC were phosphate level, dialysis vintage, parathyroid hormone level, and apoE4. Conclusion These data indicate suboptimal vitamin K status in hemodialysis patients, shown by low phylloquinone concentrations and high %ucOC in 29% and 93% of subjects, respectively. The apoE4 allele influences osteocalcin γ-carboxylation in hemodialysis patients.</abstract><cop>Orlando, FL</cop><pub>Elsevier Inc</pub><pmid>17336705</pmid><doi>10.1053/j.ajkd.2006.11.041</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0272-6386
ispartof American journal of kidney diseases, 2007-03, Vol.49 (3), p.432-439
issn 0272-6386
1523-6838
language eng
recordid cdi_proquest_miscellaneous_70219559
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Aged
Alleles
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
apolipoprotein E
Apolipoproteins E - genetics
Apolipoproteins E - physiology
Biological and medical sciences
Biological Transport - physiology
Cohort Studies
Cross-Sectional Studies
Emergency and intensive care: renal failure. Dialysis management
Female
hemodialysis
Humans
Intensive care medicine
Male
Medical sciences
Middle Aged
Nephrology
Nephrology. Urinary tract diseases
osteocalcin
Osteocalcin - metabolism
Phenotype
phylloquinone
Regression Analysis
Renal Dialysis - adverse effects
Vitamin K
Vitamin K 1 - blood
Vitamin K Deficiency - epidemiology
Vitamin K Deficiency - genetics
Vitamin K Deficiency - metabolism
γ-carboxylation
title Subclinical Vitamin K Deficiency in Hemodialysis Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T00%3A22%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Subclinical%20Vitamin%20K%20Deficiency%20in%20Hemodialysis%20Patients&rft.jtitle=American%20journal%20of%20kidney%20diseases&rft.au=Pilkey,%20Rachel%20M.,%20MD&rft.date=2007-03-01&rft.volume=49&rft.issue=3&rft.spage=432&rft.epage=439&rft.pages=432-439&rft.issn=0272-6386&rft.eissn=1523-6838&rft_id=info:doi/10.1053/j.ajkd.2006.11.041&rft_dat=%3Cproquest_cross%3E70219559%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70219559&rft_id=info:pmid/17336705&rft_els_id=S027263860601835X&rfr_iscdi=true